Insmed Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | – | +1,287.6% | +20.5% | +14.6% | +30.2% | +24.4% | +19.2% | +66.7% | |
| – | -94.1% | +23.0% | +19.0% | -16.5% | +899.3% | +64.7% | +10.7% | +24.9% | +19.0% | +30.8% | +45.6% | |
| – | – | – | – | – | +1,414.5% | +10.9% | +15.9% | +31.8% | +26.0% | +16.0% | +73.2% | |
| – | +31.9% | +65.2% | -10.6% | +32.4% | -9.3% | +37.5% | +50.6% | +45.7% | +43.6% | +4.8% | +28.9% | |
| – | +39.1% | +17.3% | +56.2% | +112.5% | +25.3% | -3.4% | +15.1% | +13.5% | +29.6% | +33.9% | +52.1% | |
| – | +34.5% | +47.6% | +9.0% | +66.6% | +10.4% | +12.2% | +33.3% | +24.7% | +46.6% | +21.8% | +43.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.6% | +21.1% | +69.4% | +329.9% | +8.8% | +6.7% | +36.9% | -34.7% | +208.9% | +3.9% | -1.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -377.6% | – | +286.6% | +80.4% | -225.4% | – | +84.7% | +45.1% | +35.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.